Oak Family Advisors, LLC Vertex Pharmaceuticals Inc Transaction History

Oak Family Advisors, LLC

  • $318 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021
SELL
$181.39 - $202.99 $673,501 - $753,701
-3,713 Closed
0 $0
Q2 2021

Jul 29, 2021
BUY
$187.49 - $221.1 $226,675 - $267,309
1,209 Added 48.28%
3,713 $749,000
Q1 2021

May 05, 2021
BUY
$207.02 - $241.31 $518,378 - $604,240
2,504 New
2,504 $538,000

Others Institutions Holding VRTX

# of Institutions
1,721
Shares Held
227M
Call Options Held
1.21M
Put Options Held
1.56M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $127B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Oak Family Advisors, LLC Portfolio

Follow Oak Family Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Family Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Family Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email